» Articles » PMID: 38892030

Nanoformulations in Pharmaceutical and Biomedical Applications: Green Perspectives

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2024 Jun 19
PMID 38892030
Authors
Affiliations
Soon will be listed here.
Abstract

This study provides a brief discussion of the major nanopharmaceuticals formulations as well as the impact of nanotechnology on the future of pharmaceuticals. Effective and eco-friendly strategies of biofabrication are also highlighted. Modern approaches to designing pharmaceutical nanoformulations (e.g., 3D printing, Phyto-Nanotechnology, Biomimetics/Bioinspiration, etc.) are outlined. This paper discusses the need to use natural resources for the "green" design of new nanoformulations with therapeutic efficiency. Nanopharmaceuticals research is still in its early stages, and the preparation of nanomaterials must be carefully considered. Therefore, safety and long-term effects of pharmaceutical nanoformulations must not be overlooked. The testing of nanopharmaceuticals represents an essential point in their further applications. Vegetal scaffolds obtained by decellularizing plant leaves represent a valuable, bioinspired model for nanopharmaceutical testing that avoids using animals. Nanoformulations are critical in various fields, especially in pharmacy, medicine, agriculture, and material science, due to their unique properties and advantages over conventional formulations that allows improved solubility, bioavailability, targeted drug delivery, controlled release, and reduced toxicity. Nanopharmaceuticals have transitioned from experimental stages to being a vital component of clinical practice, significantly improving outcomes in medical fields for cancer treatment, infectious diseases, neurological disorders, personalized medicine, and advanced diagnostics. Here are the key points highlighting their importance. The significant challenges, opportunities, and future directions are mentioned in the final section.

Citing Articles

Flavonoids and Flavonoid-Based Nanopharmaceuticals as Promising Therapeutic Strategies for Colorectal Cancer-An Updated Literature Review.

Smeu A, Marcovici I, Dehelean C, Dumitrel S, Borza C, Lighezan R Pharmaceuticals (Basel). 2025; 18(2).

PMID: 40006045 PMC: 11858883. DOI: 10.3390/ph18020231.


Progress in Drug Delivery Systems Based on Nanoparticles for Improved Glioblastoma Therapy: Addressing Challenges and Investigating Opportunities.

Rahman M, Jalouli M, Yadab M, Al-Zharani M Cancers (Basel). 2025; 17(4).

PMID: 40002294 PMC: 11852615. DOI: 10.3390/cancers17040701.


Anti-tumor potential of Harmine and its derivatives: recent trends and advancements.

Joshi H, Bhushan S, Dimri T, Sharma D, Sak K, Chauhan A Discov Oncol. 2025; 16(1):189.

PMID: 39954215 PMC: 11829886. DOI: 10.1007/s12672-025-01893-w.


Navigating a challenging path: precision disease treatment with tailored oral nano-armor-probiotics.

Chen A, Gong Y, Wu S, Du Y, Liu Z, Jiang Y J Nanobiotechnology. 2025; 23(1):72.

PMID: 39893419 PMC: 11786591. DOI: 10.1186/s12951-025-03141-3.


Curcumin-Based Nanoparticles: Advancements and Challenges in Tumor Therapy.

Wahnou H, El Kebbaj R, Liagre B, Sol V, Limami Y, Duval R Pharmaceutics. 2025; 17(1).

PMID: 39861761 PMC: 11768525. DOI: 10.3390/pharmaceutics17010114.


References
1.
Yu L . Pharmaceutical quality by design: product and process development, understanding, and control. Pharm Res. 2008; 25(4):781-91. DOI: 10.1007/s11095-007-9511-1. View

2.
Do H, Truong H . Ni, Co, Zn, and Cu metal-organic framework-based nanomaterials for electrochemical reduction of CO: A review. Beilstein J Nanotechnol. 2023; 14:904-911. PMC: 10478002. DOI: 10.3762/bjnano.14.74. View

3.
Tian C, Tang Z, Hou Y, Mushtaq A, Naz S, Yu Z . Facile Synthesis of Multifunctional Magnetoplasmonic Au-MnO Hybrid Nanocomposites for Cancer Theranostics. Nanomaterials (Basel). 2022; 12(8). PMC: 9027802. DOI: 10.3390/nano12081370. View

4.
Qiu L, Shen R, Wei L, Xu S, Xia W, Hou Y . Designing a microbial fermentation-functionalized alginate microsphere for targeted release of 5-ASA using nano dietary fiber carrier for inflammatory bowel disease treatment. J Nanobiotechnology. 2023; 21(1):344. PMC: 10517557. DOI: 10.1186/s12951-023-02097-6. View

5.
Alizadeh F, Javadi M, Karami A, Gholaminejad F, Kavianpour M, Haghighian H . Curcumin nanomicelle improves semen parameters, oxidative stress, inflammatory biomarkers, and reproductive hormones in infertile men: A randomized clinical trial. Phytother Res. 2017; 32(3):514-521. DOI: 10.1002/ptr.5998. View